Concurrent three-dimensional conformal radiotherapy and chemotherapy for postoperative recurrence of mediastinal lymph node metastases in patients with esophageal squamous cell carcinoma: a phase 2 single-institution study
Daiyuan Ma(North Sichuan Medical University), You Lü(Sichuan University), Bangxian Tan(Affiliated Hospital of North Sichuan Medical College), LI Xian-fu(North Sichuan Medical University), Mi Liu(Chinese Center For Disease Control and Prevention), Yeqin Zhou(North Sichuan Medical University)
Cited by 41
Related Papers
Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial
|The Lancet Oncology|2015|412
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer
|JNCI Journal of the National Cancer Institute|2022|267
Consensus for HER2 alterations testing in non-small-cell lung cancer
|ESMO Open|2022|110
Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial
|Radiotherapy and Oncology|2017|104
Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand
|Journal of Cancer Research and Clinical Oncology|2002|77